Showing results (51-60 of 625) with videos related to
Sort By:
Pageof 63
Biomarker Research|March 8, 2016
SOX11 is a biomarker for cyclin D1-negative mantle cell lymphomaRoshni Narurkar, Mohammad Alkayem, Delong LiuEar, Nose, & Throat Journal|February 3, 2023
Clinical Diagnosis and Treatment of Primary Laryngeal Neuroendocrine CarcinomaYu Wang, Delong Liu, Cuiping SheBiomarker Research|October 23, 2019
Correction to: Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemiaJuanjuan Zhao, Yongping Song, Delong LiuJournal of Hematology & Oncology|February 16, 2012
Current management and novel agents for malignant melanomaByung Lee, Nikhil Mukhi, Delong LiuJournal of Hematology & Oncology|June 3, 2009
New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancerShundong Cang, Yuehua Ma, Delong LiuThe Journal of Organic Chemistry|August 7, 2007
Novel C2-symmetric planar chiral diphosphine ligands and their application in pd-catalyzed asymmetric allylic substitutionsDelong Liu, Fang Xie, Wanbin ZhangBiomarker Research|December 12, 2017
<i>SETBP1</i> mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndromeKatherine Linder, Chaitanya Iragavarapu, Delong LiuJournal of Hematology & Oncology|July 6, 2019
Engineering switchable and programmable universal CARs for CAR T therapyDelong Liu, Juanjuan Zhao, Yongping SongJournal of Hematology & Oncology|September 18, 2020
BCMA-targeted immunotherapy for multiple myelomaBo Yu, Tianbo Jiang, Delong LiuJournal of Hematology & Oncology|March 9, 2016
Second- and third-generation ALK inhibitors for non-small cell lung cancerJingjing Wu, John Savooji, Delong LiuPageof 63